We are live on ! Find out more
CC

Commodore Capital Portfolio holdings

AUM $1.73B
1-Year Est. Return 298.96%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+298.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.73B
AUM Growth
+$226M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$49.8M
2
+$42.2M
3
+$37.5M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$36M
5
NUVL icon
Nuvalent
NUVL
+$28.9M

Top Sells

1
+$59.6M
2
+$53.1M
3
+$44.9M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$39.3M
5
ELVN icon
Enliven Therapeutics
ELVN
+$39.3M

Sector Composition

1 Healthcare 99.71%
2 Financials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZURA icon
26
Zura Bio
ZURA
$340M
$19.3M 1.12%
+3,250,000
SABS icon
27
SAB Biotherapeutics
SABS
$256M
$16.9M 0.98%
4,401,500
PALI icon
28
Palisade Bio
PALI
$292M
$12.6M 0.73%
7,181,062
-4,263,938
KPTI icon
29
Karyopharm Therapeutics
KPTI
$208M
$10.9M 0.63%
+1,950,000
IKT icon
30
Inhibikase Therapeutics
IKT
$223M
$9.07M 0.52%
5,397,488
ANTX icon
31
AN2 Therapeutics
ANTX
$160M
$7.98M 0.46%
+2,333,713
PEPG icon
32
PepGen
PEPG
$97.5M
$7.92M 0.46%
4,475,000
+1,075,000
AVTX icon
33
Avalo Therapeutics
AVTX
$689M
$7.21M 0.42%
483,000
HLXC
34
Helix Acquisition Corp III
HLXC
$233M
$5.08M 0.29%
+500,000
LONA
35
LeonaBio Inc
LONA
$79.8M
$4.77M 0.28%
464,398
RLMD icon
36
Relmada Therapeutics
RLMD
$679M
$4.41M 0.26%
+633,901
CTMX icon
37
CytomX Therapeutics
CTMX
$631M
– –
-7,692,300
DRUG
38
Bright Minds Biosciences
DRUG
$595M
– –
-18,851
CTNM
39
Contineum Therapeutics
CTNM
$439M
– –
-816,326
ORKA
40
Oruka Therapeutics
ORKA
$4.03B
– –
-1,753,054
CNTA
41
Centessa Pharmaceuticals
CNTA
$6.14B
– –
-1,000,000
PTGX icon
42
Protagonist Therapeutics
PTGX
$6.96B
– –
-450,000
RAPT
43
DELISTED
RAPT Therapeutics
RAPT
– –
-250,000
REPL icon
44
Replimune Group
REPL
$700M
– –
-1,425,000
TERN
45
DELISTED
Terns Pharmaceuticals
TERN
– –
-1,475,000
1
2